Press release
Uveitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Statistics, Revenue, Therapies, Prevalence and Companies by DelveInsight
Uveitis Treatment Market
The Uveitis market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Uveitis market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Uveitis treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Uveitis market.
Request for a Free Sample Report @ https://www.delveinsight.com/report-store/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of the Uveitis Market Report are:
• In March 2025, ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN (fluocinolone acetonide intravitreal implant) that includes an indication for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). The approval also includes other updates to the label including to the Warnings and Precautions section. As previously announced, the Company plans to market ILUVIEN for chronic NIU-PS in addition to its current indication of diabetic macular edema (DME) in the U.S. ILUVIEN is already approved for both DME and NIU-PS outside the U.S., including in seventeen European countries.
• The total uveitis market size of in the 7MM was approximately USD 1,468 million in 2022 and is projected to increase during the forecast period (2023-2034).
• Leading Uveitis companies working in the market are Tarsier Pharma, Oculis Pharma, Roche, Eli Lilly and Company, Acelyrin, Affibody Medical, Eyevensys, Priovant Therapeutics, Santen Inc, Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer Inc, Fera Pharmaceuticals, Teva Pharmaceutical Industries, EyePoint Pharmaceuticals, Amorphex Therapeutics Holdings, Astellas Pharma Inc, Bayer AG, Novartis, and others.
• As per DelveInsight analysis, in 2022, there were approximately 1,009,025 Uveitis diagnosed prevalent cases in the 7MM.
• The total number of Uveitis diagnosed prevalent cases in the US was around 378,281 in 2022.
• Emerging Uveitis therapies such as TRS01, OCS-02, and RG6179 can potentially create a positive shift in the uveitis market size.
• On September 23, 2024, Priovant Therapeutics announced the enrollment of the first patients in the Phase 3 CLARITY study evaluating brepocitinib for non-anterior NIU, with the FDA granting Fast Track Designation to expedite its development.
• June 2024:- Bio-Thera Solutions- A Multicenter, Prospective, Post-marketing Evaluation of QLETLI (Adalimumab Injection) Treatment Clinical Study on Efficacy and Safety of Non-infectious Uveitis (UV). This is a multicenter, prospective, post-marketing clinical study with a total of 60 uveitis (UV) subjects planned to be enrolled.
Uveitis Overview
Uveitis is a sight-threatening inflammatory disease affecting the middle uveal layer of the eye. The inflammation usually happens when the immune system fights an infection affecting the uveal tract (composed of the iris, choroid, and ciliary body) and adjacent structures (including the sclera, cornea, vitreous humor, retina, and optic nerve head).
Uveitis is one of the leading causes of visual morbidity, with over one-third of patients with uveitis having a visual impairment and accounting for about 10-15% of blindness cases worldwide. Uveitis can affect people of all ages and can vary significantly by geographic location and age of the patient. Anterior uveitis is the most prevalent form, accounting for approximately 50% of uveitis cases, while posterior uveitis is the least common.
Learn more about Uveitis treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Uveitis Market
The Uveitis market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Uveitis market trends by analyzing the impact of current Uveitis therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Uveitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Uveitis market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Uveitis market in 7MM is expected to witness a major change in the study period 2020-2034.
Uveitis Epidemiology
The Uveitis epidemiology section provides insights into the historical and current Uveitis patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Uveitis market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Uveitis Epidemiology @ https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Uveitis Drugs Uptake
This section focuses on the uptake rate of the potential Uveitis drugs recently launched in the Uveitis market or expected to be launched in 2020-2034. The analysis covers the Uveitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Uveitis Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Uveitis market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Uveitis Pipeline Development Activities
The Uveitis report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Uveitis key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Uveitis pipeline development activities @ https://www.delveinsight.com/sample-request/uveitis-market
Uveitis Therapeutics Assessment
Major key companies are working proactively in the Uveitis Therapeutics market to develop novel therapies which will drive the Uveitis treatment markets in the upcoming years are Tarsier Pharma, Oculis Pharma, Roche, Eli Lilly and Company, Acelyrin, Affibody Medical, Eyevensys, Priovant Therapeutics, Santen Inc, Aerie Pharmaceuticals, Allergan, Bausch Health, Merck, Pfizer Inc, Fera Pharmaceuticals, Teva Pharmaceutical Industries, EyePoint Pharmaceuticals, Amorphex Therapeutics Holdings, Astellas Pharma Inc, Bayer AG, Novartis, and others.
Learn more about the emerging Uveitis therapies & key companies @ https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Uveitis Report Key Insights
1. Uveitis Patient Population
2. Uveitis Market Size and Trends
3. Key Cross Competition in the Uveitis Market
4. Uveitis Market Dynamics (Key Drivers and Barriers)
5. Uveitis Market Opportunities
6. Uveitis Therapeutic Approaches
7. Uveitis Pipeline Analysis
8. Uveitis Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Uveitis Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Uveitis Competitive Intelligence Analysis
4. Uveitis Market Overview at a Glance
5. Uveitis Disease Background and Overview
6. Uveitis Patient Journey
7. Uveitis Epidemiology and Patient Population
8. Uveitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Uveitis Unmet Needs
10. Key Endpoints of Uveitis Treatment
11. Uveitis Marketed Products
12. Uveitis Emerging Therapies
13. Uveitis Seven Major Market Analysis
14. Attribute Analysis
15. Uveitis Market Outlook (7 major markets)
16. Uveitis Access and Reimbursement Overview
17. KOL Views on the Uveitis Market
18. Uveitis Market Drivers
19. Uveitis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Get the Detailed TOC of the Uveitis Market report here @ https://www.delveinsight.com/sample-request/uveitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Catheter-related Bloodstream Infections Market: https://www.delveinsight.com/report-store/catheter-related-bloodstream-infection-crbsi-market-size-analysis
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Neuroprosthetics Market: https://www.delveinsight.com/report-store/neuroprosthetics-market-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Pharma Licensing Services: https://www.delveinsight.com/consulting/licensing-services
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Acrocallosal Syndrome Market: https://www.delveinsight.com/sample-request/acrocallosal-syndrome-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-epidemiology-forecast
• Molecular Glue Trials: https://www.delveinsight.com/report-store/molecular-glues-competitive-landscape
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Cardiorenal Syndrome Market: https://www.delveinsight.com/report-store/myocardial-infarction-market
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
• Acute Intermittent Porphyria Market: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/anti-cd274-pd-l1-antibody-pipeline-insight
• Healthcare Consulting: https://www.delveinsight.com/consulting
• Healthcare Partner Identification Services: https://www.delveinsight.com/consulting/partner-identification-services
• Hereditary Spastic Paraplegias Market: https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
• Molecular Glue Market: https://www.delveinsight.com/report-store/molecular-glues-market-forecast
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/business-development-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Statistics, Revenue, Therapies, Prevalence and Companies by DelveInsight here
News-ID: 3940149 • Views: …
More Releases from DelveInsight Business Research
Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…
Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight O …
The Presbyopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Presbyopia pipeline products will significantly revolutionize the Presbyopia market dynamics.
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Idiopathic Pulmonary Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Idiopathic Pulmonary Fibrosis, offering comprehensive insights into the Idiopathic Pulmonary Fibrosis revenue trends,…
Myocardial Infarction Market Positioned for Accelerated Development Through 2034 …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast
https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
